Search COVID-19 Rapid Resource Center or explore resources sorted by Category or Content Type.
Interleukin-6 Receptor Antagonists Critically Ill patients with COVID-19 (REMAP-CAP)
This resource details using interleukin-6 receptor antagonists when treating critically Ill patients with COVID-19 (REMAP-CAP). This is SCCM curated COVID-19 microlearning content.
Faculty: Nicholas Voller, PharmD
This educational activity was funded in part by a cooperative agreement with the Centers for Disease Control and Prevention (grant number 1 NU50CK000566-01-00). The Centers for Disease Control and Prevention is an agency within the Department of Health and Human Services (HHS). Its contents do not necessarily represent the policy of CDC or HHS, and should not be considered an endorsement by the Federal Government.
Estimated Time: 11:00 min